Mortality, length of stay (LOS) and hospital charges are significantly higher in chronic liver disease (CLD) patients with fractures, a recent study has shown. These findings are also associated with increased infection, bleeding and poorer wound healing.
Exposure to antitumour necrosis factor (anti-TNF) for inflammatory bowel disease also confers benefits for the risk of acute arterial events, especially in men with Crohn’s disease (CD), as shown in a recent study.
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
The consent process may help reduce anxiety of patients undergoing colonoscopy, according to a recent study. However, written or video educational adjuncts provided on the day of colonoscopy appear to have no effect on patient perceptions when used in conjunction with a high-quality verbal consent.
Diabetic patients with hepatitis C virus (HCV) may benefit from direct-acting antiviral agents, with a significant portion of patients having a clinically significant reduction in glycated haemoglobin (HbA1c), suggests a recent study. This effect has been sustained among responders over 1.5 years of follow-up.
Among patients with ulcerative colitis, smokers and never-smokers have similar outcomes in terms of flares, thiopurine use, corticosteroid dependency, hospitalization and colectomy, a study reports. Furthermore, while smoking cessation is not associated with worse disease course, the risks associated with tobacco use outweigh any benefits.
New drug application approved by US FDA as of 01 - 15 September 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.